Fig. 1 · Structure
Documents & Downloads
Pyridoxylamine
Cat. No.
A71449
CAS
85-87-0
Endogenous Metabolite
Pyridoxylamine acts as an inhibitor of advanced glycation end products (AGEs) and lipoxidation end products (ALEs). This compound demonstrates protective effects against diabetes-induced retinal vascular lesions, making it valuable in diabetes research. Pyridoxylamine serves as a critical tool for studying the mechanisms underlying diabetic complications and may provide insights into therapeutic strategies for managing such conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 85-87-0 |
| Applications | Endogenous Metabolite |
| Formula | C8H12N2O2 |
| Molecular Weight | 168.19 |
| SMILES | OCC1=C(CN)C(O)=C(C)N=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.